Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Regeneron Pharmaceuticals logoRegeneron Pharmaceuticals REGN

Regeneron said its shareholders elected 4 Class III director nominees and 1 Class II director nominee at the annual meeting held on June 14, 2024. Class III directors will serve until the 2027 annual meeting, and the Class II director will serve until the 2026 annual meeting.

8-KSubmission of Matters to a Vote of Security HoldersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Regeneron said its shareholders elected 4 Class III director nominees and 1 Class II director nominee at the annual meeting held on June 14, 2024. Class III directors will serve until the 2027 annual meeting, and the Class II director will serve until the 2026 annual meeting.

  2. The company said Class III director nominee Arthur F. Ryan received 81,009,658 votes for, 31,288,101 against and 156,782 abstentions. Ryan drew the most votes against among the 5 director nominees, and there were 4,213,730 broker non-votes.

  3. Regeneron said shareholders approved the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024, with 111,350,016 votes for and 5,257,636 against. The advisory vote on executive compensation was also approved, with 106,667,264 votes for and 5,579,814 against.

  4. The company said a non-binding shareholder proposal requesting simple majority voting requirements was approved, with 85,900,254 votes for, 26,365,621 against and 188,666 abstentions. There were 4,213,730 broker non-votes.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Regeneron elects 5 directors at June 14, 2024 annual meeting

Regeneron said its shareholders elected 4 Class III director nominees and 1 Class II director nominee at the annual meeting held on June 14, 2024. Class III directors will serve until the 2027 annual meeting, and the Class II director will serve until the 2026 annual meeting.

Source · Based on the filing body and exhibits

Arthur F. Ryan director election vote results

The company said Class III director nominee Arthur F. Ryan received 81,009,658 votes for, 31,288,101 against and 156,782 abstentions. Ryan drew the most votes against among the 5 director nominees, and there were 4,213,730 broker non-votes.

Source · Based on the filing body and exhibits

Accounting firm appointment and executive pay advisory vote approved

Regeneron said shareholders approved the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024, with 111,350,016 votes for and 5,257,636 against. The advisory vote on executive compensation was also approved, with 106,667,264 votes for and 5,579,814 against.

Source · Based on the filing body and exhibits

Non-binding shareholder proposal on simple majority voting approved

The company said a non-binding shareholder proposal requesting simple majority voting requirements was approved, with 85,900,254 votes for, 26,365,621 against and 188,666 abstentions. There were 4,213,730 broker non-votes.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.